Pharmajet, Inc.
PharmaJet is dedicated to improving public health by developing and commercializing needle-free injection technology that enhances vaccine effectiveness, safety, and patient experience. Their systems are used for delivering vaccines and medications intradermally, intramuscularly, or subcutaneously, with a focus on global health initiatives and innovative vaccine delivery methods.
Industries
Nr. of Employees
small (1-50)
Pharmajet, Inc.
400 Corporate Circle, Suite N, Golden, Colorado, USA 80401
Patents
Products
Hand-held needle-free intradermal jet injection device
A hand-held device that delivers intradermal injections via a pressurized liquid jet stream to enable fractional-dose intradermal vaccination without a needle.
Needle-free intramuscular/subcutaneous jet injection system
A precision delivery system intended to administer medications and vaccines intramuscularly or subcutaneously using needle-free jet injection.
Hand-held needle-free intradermal jet injection device
A hand-held device that delivers intradermal injections via a pressurized liquid jet stream to enable fractional-dose intradermal vaccination without a needle.
Needle-free intramuscular/subcutaneous jet injection system
A precision delivery system intended to administer medications and vaccines intramuscularly or subcutaneously using needle-free jet injection.
Services
Provision of device platforms and operational support for clinical studies delivering vaccines and biologics without needles, including coordination with sponsor trial teams.
Design and execution of implementation studies (including stratified-pair cluster randomized and mixed-methods approaches) to measure coverage, costs, feasibility, and scalability of delivery interventions.
Operational support for deployment of needle-free injection systems in mass immunization and eradication campaigns, including coordination with WHO and local implementers.
Identification and management of collaborations with public-sector funders, global health agencies, NGOs, and private-sector partners to advance delivery technologies and program adoption.
Provision of device platforms and operational support for clinical studies delivering vaccines and biologics without needles, including coordination with sponsor trial teams.
Design and execution of implementation studies (including stratified-pair cluster randomized and mixed-methods approaches) to measure coverage, costs, feasibility, and scalability of delivery interventions.
Operational support for deployment of needle-free injection systems in mass immunization and eradication campaigns, including coordination with WHO and local implementers.
Identification and management of collaborations with public-sector funders, global health agencies, NGOs, and private-sector partners to advance delivery technologies and program adoption.
Expertise Areas
- Needle-free vaccine delivery
- Implementation research for immunization programs
- Clinical trial delivery support
- Dose-sparing intradermal vaccination strategies
Key Technologies
- Jet injection (needle-free) systems
- Intradermal fractional-dose administration
- Intramuscular/subcutaneous jet injection
- Nucleic acid vaccine delivery (DNA, mRNA, sa-mRNA)
News & Updates
PharmaJet will participate in the International Bio Convention in Boston, Massachusetts, USA, from June 16-19, 2025, Booth #3545.
A study demonstrating the benefits of needle-free intradermal delivery of inactivated polio vaccine.
A study demonstrating the benefits of PharmaJet Tropis needle-free system for fractional dose poliovirus.
PharmaJet’s Tropis system was used in the WHO polio eradication campaign in Pakistan.
A study on COVID-19 vaccine booster responses using PharmaJet Tropis.
PharmaJet will participate in the International Bio Convention in Boston, Massachusetts, USA, from June 16-19, 2025, Booth #3545.
A study demonstrating the benefits of needle-free intradermal delivery of inactivated polio vaccine.
A study demonstrating the benefits of PharmaJet Tropis needle-free system for fractional dose poliovirus.
PharmaJet’s Tropis system was used in the WHO polio eradication campaign in Pakistan.
A study on COVID-19 vaccine booster responses using PharmaJet Tropis.